These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

643 related items for PubMed ID: 28865098

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Efficacy and safety of hangeshashinto for treatment of GERD refractory to proton pump inhibitors : Usual dose proton pump inhibitors plus hangeshashinto versus double-dose proton pump inhibitors: randomized, multicenter open label exploratory study.
    Takeuchi T, Hongo H, Kimura T, Kojima Y, Harada S, Ota K, Takeuchi N, Noguchi T, Inoue T, Murano M, Higuchi K.
    J Gastroenterol; 2019 Nov; 54(11):972-983. PubMed ID: 31037449
    [Abstract] [Full Text] [Related]

  • 3. Efficacy of acotiamide in combination with esomeprazole for functional dyspepsia refractory to proton-pump inhibitor monotherapy.
    Mayanagi S, Kishino M, Kitagawa Y, Sunamura M.
    Tohoku J Exp Med; 2014 Nov; 234(3):237-40. PubMed ID: 25382232
    [Abstract] [Full Text] [Related]

  • 4. Improvement of meal-related symptoms and epigastric pain in patients with functional dyspepsia treated with acotiamide was associated with acylated ghrelin levels in Japan.
    Yamawaki H, Futagami S, Kawagoe T, Maruki Y, Hashimoto S, Nagoya H, Sato H, Kodaka Y, Gudis K, Akamizu T, Sakamoto C, Iwakiri K.
    Neurogastroenterol Motil; 2016 Jul; 28(7):1037-47. PubMed ID: 26920949
    [Abstract] [Full Text] [Related]

  • 5. Sleep disturbances and refractory gastroesophageal reflux disease symptoms in patients receiving once-daily proton pump inhibitors and efficacy of twice-daily rabeprazole treatment.
    Fujiwara Y, Habu Y, Ashida K, Kusano M, Higuchi K, Arakawa T.
    Digestion; 2013 Jul; 88(3):145-52. PubMed ID: 24008338
    [Abstract] [Full Text] [Related]

  • 6. Effects of acotiamide on functional dyspepsia patients with heartburn who failed proton pump inhibitor treatment in Japanese patients: A randomized, double-blind, placebo-controlled crossover study.
    Funaki Y, Ogasawara N, Kawamura Y, Yoshimine T, Tamura Y, Izawa S, Ebi M, Sasaki M, Kasugai K.
    Neurogastroenterol Motil; 2020 Feb; 32(2):e13749. PubMed ID: 31612597
    [Abstract] [Full Text] [Related]

  • 7. Characteristics of refractory gastroesophageal reflux disease (GERD) symptoms -is switching proton pump inhibitors based on the patient's CYP2C19 genotype an effective management strategy?
    Takeuchi T, Oota K, Harada S, Edogawa S, Kojima Y, Sanomura M, Sakaguchi M, Hayashi K, Hongoh Y, Itabashi T, Kitae H, Hoshimoto M, Takeuchi N, Higuchi K.
    Intern Med; 2015 Feb; 54(2):97-105. PubMed ID: 25742999
    [Abstract] [Full Text] [Related]

  • 8. Pretreatment prediction of symptom response to proton pump inhibitor therapy.
    Nagahara A, Miwa H, Asaoka D, Shimada Y, Sasaki H, Matsumoto K, Osada T, Hojo M, Watanabe S.
    J Gastroenterol Hepatol; 2015 Mar; 30 Suppl 1():25-30. PubMed ID: 25827800
    [Abstract] [Full Text] [Related]

  • 9. Proton pump inhibitor monotherapy is effective to attenuate dyspepsia symptoms associated with gastroesophageal reflux disease: a multicenter prospective observational study.
    Isshi K, Matsuhashi N, Joh T, Higuchi K, Iwakiri K, Kamiya T, Manabe N, Ogawa M, Arihiro S, Haruma K, Nakada K.
    J Gastroenterol; 2019 Jun; 54(6):492-500. PubMed ID: 30673836
    [Abstract] [Full Text] [Related]

  • 10. Investigation of pretreatment prediction of proton pump inhibitor (PPI)-resistant patients with gastroesophageal reflux disease and the dose escalation challenge of PPIs-TORNADO study: a multicenter prospective study by the Acid-Related Symptom Research Group in Japan.
    Furuta T, Shimatani T, Sugimoto M, Ishihara S, Fujiwara Y, Kusano M, Koike T, Hongo M, Chiba T, Kinoshita Y, Acid-Related Symptom Research Group.
    J Gastroenterol; 2011 Nov; 46(11):1273-83. PubMed ID: 21861141
    [Abstract] [Full Text] [Related]

  • 11. Adding Acotiamide to Gastric Acid Inhibitors Is Effective for Treating Refractory Symptoms in Patients with Non-erosive Reflux Disease.
    Yamashita H, Okada A, Naora K, Hongoh M, Kinoshita Y.
    Dig Dis Sci; 2019 Mar; 64(3):823-831. PubMed ID: 30465175
    [Abstract] [Full Text] [Related]

  • 12. Prevalence and symptom pattern of pathologic esophageal acid reflux in patients with functional dyspepsia based on the Rome III criteria.
    Xiao YL, Peng S, Tao J, Wang AJ, Lin JK, Hu PJ, Chen MH.
    Am J Gastroenterol; 2010 Dec; 105(12):2626-31. PubMed ID: 20823838
    [Abstract] [Full Text] [Related]

  • 13. Efficacy and safety of twice-daily rabeprazole maintenance therapy for patients with reflux esophagitis refractory to standard once-daily proton pump inhibitor: the Japan-based EXTEND study.
    Kinoshita Y, Kato M, Fujishiro M, Masuyama H, Nakata R, Abe H, Kumagai S, Fukushima Y, Okubo Y, Hojo S, Kusano M.
    J Gastroenterol; 2018 Jul; 53(7):834-844. PubMed ID: 29188387
    [Abstract] [Full Text] [Related]

  • 14. Causal effect of anxiety and depression status on the symptoms of gastroesophageal reflux disease and functional dyspepsia during proton pump inhibitor therapy.
    Nakada K, Oshio A, Matsuhashi N, Iwakiri K, Kamiya T, Manabe N, Joh T, Higuchi K, Haruma K.
    Esophagus; 2023 Apr; 20(2):309-316. PubMed ID: 36251168
    [Abstract] [Full Text] [Related]

  • 15. Proton pump inhibitors improve acid-related dyspepsia in gastroesophageal reflux disease patients.
    Kusano M, Shimoyama Y, Kawamura O, Maeda M, Kuribayashi S, Nagoshi A, Zai H, Moki F, Horikoshi T, Toki M, Sugimoto S, Mori M.
    Dig Dis Sci; 2007 Jul; 52(7):1673-7. PubMed ID: 17385034
    [Abstract] [Full Text] [Related]

  • 16. A Randomized, Double-Blind, Pilot Study of the Effect of Famotidine on Acotiamide Treatment for Functional Dyspepsia.
    Hojo M, Nagahara A, Asaoka D, Takeda T, Izumi K, Matsumoto K, Ueyama H, Shimada Y, Matsumoto K, Nojiri S, Watanabe S.
    Digestion; 2017 Jul; 96(1):5-12. PubMed ID: 28605740
    [Abstract] [Full Text] [Related]

  • 17. Validation of a short questionnaire in English and French for use in patients with persistent upper gastrointestinal symptoms despite proton pump inhibitor therapy: the PASS (Proton pump inhibitor Acid Suppression Symptom) test.
    Armstrong D, Veldhuyzen SJ, Chung SA, Shapiro CM, Dhillon S, Escobedo S, Chakraborty BK, Mann V, Tanser L, Nevin K.
    Can J Gastroenterol; 2005 Jun; 19(6):350-8. PubMed ID: 15997268
    [Abstract] [Full Text] [Related]

  • 18. Observational comparative trial of the efficacy of proton pump inhibitors versus histamine-2 receptor antagonists for uninvestigated dyspepsia.
    Nagahara A, Asaoka D, Hojo M, Oguro M, Shimada Y, Ishikawa D, Osada T, Kawabe M, Yoshizawa T, Otaka M, Watanabe S.
    J Gastroenterol Hepatol; 2010 May; 25 Suppl 1():S122-8. PubMed ID: 20586853
    [Abstract] [Full Text] [Related]

  • 19. Rikkunshito improves symptoms in PPI-refractory GERD patients: a prospective, randomized, multicenter trial in Japan.
    Tominaga K, Iwakiri R, Fujimoto K, Fujiwara Y, Tanaka M, Shimoyama Y, Umegaki E, Higuchi K, Kusano M, Arakawa T, GERD 4 Study Group.
    J Gastroenterol; 2012 Mar; 47(3):284-92. PubMed ID: 22081052
    [Abstract] [Full Text] [Related]

  • 20. Clinical efficacy of Yukgunja-tang combined with a proton pump inhibitor for refractory gastroesophageal reflux disease: study protocol for randomized, double-blind, double-dummy clinical trial.
    Ha NY, Kim JW, Kim J.
    BMC Complement Med Ther; 2023 Dec 07; 23(1):444. PubMed ID: 38062418
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.